Ijraset Journal For Research in Applied Science and Engineering Technology
Authors: Krishna Bharathi R, Ghriti B Amin, Keerthana RV, Rajha Sacheen VS
DOI Link: https://doi.org/10.22214/ijraset.2025.66474
Certificate: View Certificate
The early detection and diagnosis of skin diseases are crucial for effective treatment and management. This paper presents DermaSense AI, an innovative platform that leverages Convolutional Neural Networks (CNNs), specifically the InceptionV3 architecture, to automate the detection of skin diseases with high accuracy. By integrating with Telegram, a popular messaging platform, DermaSense AI offers a user-friendly interface for preliminary diagnosis, enabling users to upload images for analysis. The system addresses challenges in dermatological care, such as limited access, high costs, and subjective diagnostics, by providing a scalable, cost-effective, and efficient solution. This study outlines the development, implementation, and testing of the DermaSense AI platform, demonstrating its potential to enhance dermatological care globally through accessible and reliable diagnostics.
I. INTRODUCTION
Skin diseases, ranging from benign conditions like acne to severe disorders like melanoma, significantly impact global health. The accurate diagnosis and timely treatment of these conditions are critical for improving patient outcomes. However, barriers such as a shortage of dermatologists, high diagnostic costs, and limited access to care in rural areas hinder effective healthcare delivery.
Artificial Intelligence (AI), particularly through Convolutional Neural Networks (CNNs), has emerged as a transformative tool in medical diagnostics. CNNs excel in image recognition tasks, making them ideal for dermatological applications. DermaSense AI leverages the power of CNNs to provide accessible, accurate, and cost-effective diagnostic solutions via a Telegram-based interface. By addressing the limitations of traditional diagnostic methods, DermaSense AI aims to revolutionize dermatological care and empower users to take control of their skin health.
II. OBJECTIVES
DermaSense AI is designed with the following objectives:
III. LITERATURE REVIEW
A. Application of AI in Dermatolog
AI has demonstrated significant potential in dermatological diagnostics. Esteva et al. (2017) highlighted that AI models could achieve dermatologist-level accuracy in melanoma detection. Similarly, platforms like SkinVision and MoleMapper utilize machine learning algorithms to assess skin lesions and track mole changes, providing users with preliminary insights. These platforms underline the transformative potential of AI in dermatology but also expose gaps in accessibility, scalability, and integration with clinical workflows.
B. Advances in CNN Architecture
Modern CNN architectures, including ResNet, VGGNet, and InceptionV3, have been extensively used for medical image analysis. InceptionV3, in particular, excels in feature extraction and classification due to its factorized convolutions, inception modules, and batch normalization techniques. Its ability to analyze high-dimensional data with minimal computational resources makes it suitable for real-time dermatological applications.
C. Datasets and Pre-processing
The success of AI in dermatology heavily relies on the availability of diverse and well-annotated datasets. The DermaNet dataset, used in DermaSense AI, includes thousands of labeled images across various skin conditions, ensuring robust model training and validation. Key preprocessing techniques such as resizing, normalization, and data augmentation improve model performance by addressing issues like dataset imbalance and variability in image quality.
D. Challenges and Limitations
Existing AI platforms face challenges including:
IV. METHODOLOGY
A. AI Model
The InceptionV3 CNN architecture was fine-tuned on the DermaNet dataset, which includes thousands of labeled dermatological images. The architecture is optimized for:
Fig 1 : Model Architecture
B. Image Preprocessing
Preprocessing techniques ensure the model’s robustness and generalizability:
C. Workflow
D. Integration with Telegram
The Telegram bot provides:
E. Validation and Testing
Fig 2 : Graph of training and validation accuracy
V. SOFTWARE REQUIREMENTS
A. Machine Learning Frameworks
B. Programming Languages
C. Messaging Platform API
Fig 3 : Telegram bot
D. Database Management Systems
E. Cloud Computing Services
F. Web Frameworks and APIs
G. Monitoring and Logging Tools
By combining these software components, DermaSense AI ensures seamless functionality, user-friendly interactions, and high diagnostic accuracy while maintaining data security and scalability.
VI. CONTROL FLOW
The control flow for DermaSense AI has been designed to optimize user interaction and system performance. Each step in the flow ensures accurate diagnostics and user satisfaction:
VII. SYSTEM ARCHITECTURE
The system architecture of DermaSense AI ensures modularity, scalability, and security. Below are the detailed components and their functions:
Fig 4 : User Interface
Fig 5 : CNN Architecture
VIII. IMPLEMENTATION
The process of implementing DermaSense AI involved several steps, starting with dataset preparation. The DermaNet dataset, which contains labeled images of various skin conditions, was used to train the machine learning model. Preprocessing techniques such as resizing images to match the input dimensions of the InceptionV3 architecture and normalizing pixel values were applied to improve model efficiency. Data augmentation methods, including rotation, flipping, and zooming, were employed to enhance dataset diversity and ensure robust performance.
This architecture utilized the Convolutional Neural Network model from InceptionV3. That architecture was best known for producing the most top-notch image recognition results, offering features like factorized convolutions in order to diminish computational costs; auxiliary classifiers mitigate vanishing gradients; and finally, global average pooling that works to reduce the chances of overfitting the model. Then, this network was implemented through TensorFlow and the Keras frameworks with an Adam optimizer and learning rate of 0.001. Multi-class classification was used with the categorical cross-entropy loss function and early stopping mechanisms to prevent overfitting.
This model was further integrated with a Telegram bot to deliver the system to end users in a user-friendly manner. Utilizing the Telegram Bot API, users could upload images from their skin conditions directly from within the Telegram platform. The Flask-based backend server handled image preprocessing, model inference, and communication with the bot. As soon as the image was submitted to the system, diagnostic results, including the probable condition and confidence scores, were delivered flawlesssly within seconds.
IX. RESULTS
The implementation successfully classified skin conditions with high accuracy and reliability. Through a Telegram bot, users were allowed to upload their images for more detailed diagnostic results, such as probable conditions and recommendations in real time. Case studies focused on how it could actually aid in proper preliminary diagnoses so as to allow access to prompt consultations with the help of physicians, thus illustrating potential improvements for better dermatological care, particularly for underdeveloped regions, based on this interface advanced by AI integration.
Fig 6 : Detection and Remedies
DermaSense AI represents a transformative leap in dermatological care by harnessing the power of artificial intelligence to offer precise, accessible, and affordable diagnostic services. Its seamless integration with Telegram ensures that users have a user-friendly experience, while the scalable backend architecture supports the platform’s potential to handle a growing number of users. These elements combine to make DermaSense AI not just a tool, but a comprehensive solution in dermatology. As the platform evolves, future developments will aim to broaden diagnostic capabilities, thereby increasing its reliability across a wider spectrum of skin conditions, including rare diseases. Enhanced model explainability will empower users by providing understandable and actionable insights, fostering trust and transparency. Moreover, by integrating with broader healthcare networks and launching dedicated mobile applications, DermaSense AI will ensure even greater accessibility and utility, bridging the gap between advanced AI diagnostics and everyday healthcare needs. This ongoing commitment to innovation and user-centric design positions DermaSense AI at the forefront of digital health solutions, revolutionizing the way dermatological care is delivered worldwide.
[1] Wongvibulsin, S., & Lee, I. (2025). Artificial Intelligence and Dermatology. JAMA Dermatology. [2] Frontiers in Medicine (2023). Principles, Applications, and Future of AI in Dermatology. [3] Satya-Akunuri, S. K., & Burkhart, C. G. (2023). Artificial Intelligence in Dermatology: Current Uses, Shortfalls, and Potential Opportunities for Further Implementation in Diagnostics and Care. The Open Dermatology Journal. [4] Liopyris, K., Gregoriou, S., Dias, J., & Stratigos, A. J. (2022). Artificial Intelligence in Dermatology: Challenges and Perspectives. Dermatology and Therapy, 12, 2637-2651. [5] Goyal, M., Yap, M. H. (2020). Artificial Intelligence in Dermatology: Current Uses and Future Opportunities. IEEE Journal of Biomedical and Health Informatics. [6] Esteva, A., et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115-118. [7] Szegedy, C., et al. (2016). Rethinking the Inception Architecture for Computer Vision. Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition. [8] Ronneberger, O., et al. (2015). U-Net: Convolutional Networks for Biomedical Image Segmentation. MICCAI.
Copyright © 2025 Krishna Bharathi R, Ghriti B Amin, Keerthana RV, Rajha Sacheen VS. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Paper Id : IJRASET66474
Publish Date : 2025-01-11
ISSN : 2321-9653
Publisher Name : IJRASET
DOI Link : Click Here